GIANT BIOGENE(02367.HK) closed 7.89% higher, The full-day turnover stood at HKD 541.86 million
NewTimeSpace News: By the close of trading on Apr 21, 2026, GIANT BIOGENE(02367.HK) saw a gain of 7.89% in its share price, closing at HKD 32. During the session, it reached an intraday high of HKD 32.3 and touched an intraday low of HKD 29.8. The full-day turnover stood at HKD 541.86 million, with significant volume growth, with the latest market capitalization at HKD 33.97 billion.
On the sector front, the Hang Seng Healthcare Equipment & Services Sector, to which GIANT BIOGENE belongs, showed an overall divergence trend, with 38 stocks advancing and 56 stocks declining.Among the gainers, RIMAG GROUP closed higher by 11.19%, GIANT BIOGENE closed higher by 7.89%, GAUSH MEDITECH closed higher by 6.35%, MEIHAO GROUP closed higher by 6.25%, MAO GEPING closed higher by 4.62%.Among the decliners, MAXWIN INT HLDG closed lower by 15.63%, REPUBLIC HC closed lower by 11.35%, MODERNHEALTHTEC closed lower by 9.52%, GBG HOLDINGS closed lower by 8.23%, MP CARDIOFLOW-B closed lower by 6.98%.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- GIANT BIOGENE(02367.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 939.71 million, YoY decrease of 20.5%
- GIANT BIOGENE(02367.HK): Cross-linked Recombinant Collagen Implant Obtains NMPA Medical Device Registration Certificate, World’s First Filler Indicated for Neck Wrinkle Correction
- GIANT BIOGENE(02367.HK) will spend HKD 13.76 million to repurchase 400 thousand shares on Jan 9, 2026